Institutional investors purchased a net $12.8 million shares of CRIS during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 54.61% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 1.1 Million shares of Curis Inc
ERGOTELES LLC Bought 598.1 Thousand shares of Curis Inc
FOCUSED WEALTH MANAGEMENT, INC. Bought 289.2 Thousand shares of Curis Inc